RemeGen Co., Ltd. (9995.HK)

HKD 15.52

(-0.26%)

Gross Profit Summary of RemeGen Co., Ltd.

RemeGen Co., Ltd.'s latest annual gross profit in 2023 was 822.99 Million CNY , up 65.31% from previous year.
RemeGen Co., Ltd.'s latest quarterly gross profit in 2024 Q2 was 314.94 Million CNY , up 22.99% from previous quarter.
RemeGen Co., Ltd. reported a annual gross profit of 497.83 Million CNY in annual gross profit 2022, down -63.31% from previous year.
RemeGen Co., Ltd. reported a annual gross profit of 1.35 Billion CNY in annual gross profit 2021, down 0.0% from previous year.
RemeGen Co., Ltd. reported a quarterly gross profit of 256.07 Million CNY for 2024 Q1, up 9.43% from previous quarter.
RemeGen Co., Ltd. reported a quarterly gross profit of 275.25 Million CNY for 2023 Q3, up 57.07% from previous quarter.

Annual Gross Profit Chart of RemeGen Co., Ltd. (2023 - 2018)

Historical Annual Gross Profit of RemeGen Co., Ltd. (2023 - 2018)

Year	Gross Profit	Gross Profit Growth
2023	822.99 Million CNY	65.31%
2022	497.83 Million CNY	-63.31%
2021	1.35 Billion CNY	0.0%
2020	- CNY	0.0%
2019	- CNY	-100.0%
2018	2.38 Million CNY	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q2	314.94 Million CNY	22.99%
2024 Q1	256.07 Million CNY	9.43%
2023 Q3	275.25 Million CNY	57.07%
2023 FY	822.99 Million CNY	65.31%
2023 Q4	234 Million CNY	-14.98%
2023 Q2	175.24 Million CNY	22.43%
2023 Q1	143.13 Million CNY	-5.69%
2022 Q3	164.79 Million CNY	27.14%
2022 Q1	52.62 Million CNY	-95.8%
2022 Q2	129.61 Million CNY	146.29%
2022 FY	497.83 Million CNY	-63.31%
2022 Q4	151.77 Million CNY	-7.9%
2021 Q3	79.69 Million CNY	270.02%
2021 Q1	3.01 Million CNY	0.0%
2021 FY	1.35 Billion CNY	0.0%
2021 Q2	21.53 Million CNY	614.91%
2021 Q4	1.25 Billion CNY	1471.52%
2020 Q3	- CNY	0.0%
2020 Q4	- CNY	0.0%
2020 Q2	- CNY	0.0%
2020 Q1	- CNY	0.0%
2020 FY	- CNY	0.0%
2019 Q1	- CNY	0.0%
2019 FY	- CNY	-100.0%
2019 Q4	- CNY	0.0%
2019 Q3	- CNY	0.0%
2019 Q2	- CNY	0.0%
2018 Q4	- CNY	0.0%
2018 Q2	597.25 Thousand CNY	0.0%
2018 Q1	597.25 Thousand CNY	0.0%
2018 FY	2.38 Million CNY	0.0%
2017 Q4	597.25 Thousand CNY	0.0%

Peer Gross Profit Comparison of RemeGen Co., Ltd.

Name	Gross Profit	Gross Profit Difference
Uni-Bio Science Group Limited	392.81 Million HKD	-109.51%
CK Life Sciences Int'l., (Holdings) Inc.	947.7 Million HKD	13.159%